{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:22:33Z","timestamp":1795216953092,"version":"4.10.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Plan","award":["2025KY1639"],"award-info":[{"award-number":["2025KY1639"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12028-025-02257-6","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:20:18Z","timestamp":1744104018000},"page":"572-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolomics Analysis Reveals Potential Biomarkers for Diffuse Axonal Injury Article Category: Original Work"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-6130","authenticated-orcid":false,"given":"Weiliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.887818","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Wang G, Yao C, et al. The ratio of serum neuron-specific enolase level to admission glasgow coma scale score is associated with diffuse axonal injury in patients with moderate to severe traumatic brain injury. Front Neurol. 2022;13: 887818.","journal-title":"Front Neurol"},{"key":"2257_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14737159.2024.2303319","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li Z, Wang H, Pei Z, Zhao S. Molecular biomarkers of diffuse axonal injury: recent advances and future perspectives. Expert Rev Mol Diagn. 2024;24:39\u201347.","journal-title":"Expert Rev Mol Diagn"},{"key":"2257_CR3","doi-asserted-by":"publisher","first-page":"1077858","DOI":"10.3389\/fnins.2023.1077858","volume":"17","author":"W Chen","year":"2023","unstructured":"Chen W, Yao C, Li S, et al. Cognitive impairment in diffuse axonal injury patients with favorable outcome. Front Neurosci-Switz. 2023;17:1077858.","journal-title":"Front Neurosci-Switz"},{"key":"2257_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.legalmed.2019.02.001","volume":"37","author":"F Wang","year":"2019","unstructured":"Wang F, Yang T, Li J, Zhou X, Liu L. Histopathology mapping of biochemical changes in diffuse axonal injury by FTIR micro-spectroscopy. Legal Med-Tokyo. 2019;37:76\u201382.","journal-title":"Legal Med-Tokyo"},{"key":"2257_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108166","volume":"237","author":"T Hazwani","year":"2024","unstructured":"Hazwani T, Khalifa AM, Azzubi M, et al. Diffuse axonal injury on magnetic resonance imaging and its relation to neurological outcomes in pediatric traumatic brain injury. Clin Neurol Neurosur. 2024;237: 108166.","journal-title":"Clin Neurol Neurosur"},{"key":"2257_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12028-021-01336-8","volume":"36","author":"AM Janas","year":"2022","unstructured":"Janas AM, Qin F, Hamilton S, et al. Diffuse axonal injury grade on early MRI is associated with worse outcome in children with moderate-severe traumatic brain injury. Neurocrit Care. 2022;36:492\u2013503.","journal-title":"Neurocrit Care"},{"key":"2257_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/brain\/awaa447","volume":"144","author":"D Benjamini","year":"2021","unstructured":"Benjamini D, Iacono D, Komlosh ME, et al. Diffuse axonal injury has a characteristic multidimensional MRI signature in the human brain. Brain. 2021;144:800\u201316.","journal-title":"Brain"},{"key":"2257_CR8","volume":"14","author":"SS Lalwani","year":"2022","unstructured":"Lalwani SS, Dadgal R, Harjpal P, Saifee SS, Lakkadsha TM. Perks of early physical therapy rehabilitation for a patient with diffuse axonal injury. Cureus J Med Sci. 2022;14: e30886.","journal-title":"Cureus J Med Sci"},{"key":"2257_CR9","first-page":"6","volume":"32","author":"M Kim","year":"2022","unstructured":"Kim M, Hong SK, Jeon SR, Roh SW, Lee S. Treatment outcome and risk factors associated with diffuse axonal injury in patients with moderate to severe head injury. Turk Neurosurg. 2022;32:6\u201315.","journal-title":"Turk Neurosurg"},{"key":"2257_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.704576","volume":"12","author":"SS Lang","year":"2021","unstructured":"Lang SS, Kilbaugh T, Friess S, et al. Trajectory of long-term outcome in severe pediatric diffuse axonal injury: an exploratory study. Front Neurol. 2021;12: 704576.","journal-title":"Front Neurol"},{"issue":"6","key":"2257_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/metabo13060694","volume":"3","author":"A Jaguri","year":"2023","unstructured":"Jaguri A, Al TA, Elrayess MA. Exercise metabolome: insights for health and performance. Metabolites. 2023;3(6):694.","journal-title":"Metabolites"},{"key":"2257_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154739","volume":"118","author":"D Shi","year":"2021","unstructured":"Shi D, Yan R, Lv L, et al. The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism. 2021;118: 154739.","journal-title":"Metabolism"},{"key":"2257_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016957","volume":"6","author":"N Psychogios","year":"2011","unstructured":"Psychogios N, Hau DD, Peng J, et al. The human serum metabolome. PLoS ONE. 2011;6: e16957.","journal-title":"PLoS ONE"},{"key":"2257_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120812","volume":"453","author":"K Wang","year":"2023","unstructured":"Wang K, Theeke LA, Liao C, et al. Deep learning analysis of UPLC-MS\/MS-based metabolomics data to predict Alzheimer\u2019s disease. J Neurol Sci. 2023;453: 120812.","journal-title":"J Neurol Sci"},{"key":"2257_CR15","doi-asserted-by":"publisher","first-page":"1101524","DOI":"10.3389\/fneur.2022.1101524","volume":"13","author":"N Lasica","year":"2022","unstructured":"Lasica N, Raicevic V, Stojanovic NM, et al. Metabolomics as a potential tool for monitoring patients with aneurysmal subarachnoid hemorrhage. Front Neurol. 2022;13:1101524.","journal-title":"Front Neurol"},{"key":"2257_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12868-023-00824-1","volume":"24","author":"RP Fedoruk","year":"2023","unstructured":"Fedoruk RP, Lee CH, Banoei MM, Winston BW. Metabolomics in severe traumatic brain injury: a scoping review. BMC Neurosci. 2023;24:54.","journal-title":"BMC Neurosci"},{"key":"2257_CR17","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1089\/neu.2017.5326","volume":"35","author":"MM Banoei","year":"2018","unstructured":"Banoei MM, Casault C, Metwaly SM, Winston BW. Metabolomics and biomarker discovery in traumatic brain injury. J Neurotraum. 2018;35:1831\u201348.","journal-title":"J Neurotraum"},{"key":"2257_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Bio. 2016;17:451\u20139.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"2257_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-030-77252-9_11","volume":"1336","author":"AN Macedo","year":"2021","unstructured":"Macedo AN, Faccio AT, Fukuji TS, Canuto G, Tavares M. Analytical platforms for mass spectrometry-based metabolomics of polar and ionizable metabolites. Adv Exp Med Biol. 2021;1336:215\u201342.","journal-title":"Adv Exp Med Biol"},{"key":"2257_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpba.2017.03.068","volume":"142","author":"B Dieme","year":"2017","unstructured":"Dieme B, Lefevre A, Nadal-Desbarats L, et al. Workflow methodology for rat brain metabolome exploration using NMR, LC-MS and GC-MS analytical platforms. J Pharmaceut Biomed. 2017;142:270\u20138.","journal-title":"J Pharmaceut Biomed"},{"key":"2257_CR21","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.3171\/sup.1991.75.1s.0s14","volume":"75","author":"LF Marshall","year":"1991","unstructured":"Marshall LF, Marshall SB, Klauber MR, Clark MVB, Foulkes MA. A new classification of head injury based on computerized tomography. J Neurosurg. 1991;75:S14\u201320.","journal-title":"J Neurosurg"},{"issue":"3","key":"2257_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/brain\/awaa447","volume":"144","author":"D Benjamini","year":"2021","unstructured":"Benjamini D, Iacono D, Komlosh ME, et al. Diffuse axonal injury has a characteristic multidimensional MRI signature in the human brain. Brain. 2021;144(3):800\u201316.","journal-title":"Brain"},{"key":"2257_CR23","doi-asserted-by":"publisher","first-page":"887818","DOI":"10.3389\/fneur.2022.887818","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Wang G, Yao C, et al. The ratio of serum neuron-specific enolase level to admission glasgow coma scale score is associated with diffuse axonal injury in patients with moderate to severe traumatic brain injury. Front Neurol. 2022;13:887818.","journal-title":"Front Neurol"},{"issue":"2","key":"2257_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12028-021-01336-8","volume":"36","author":"AM Janas","year":"2021","unstructured":"Janas AM, Qin F, Hamilton S, et al. Diffuse axonal injury grade on early MRI is associated with worse outcome in children with moderate-severe traumatic brain injury. Neurocrit Care. 2021;36(2):492\u2013503. https:\/\/doi.org\/10.1007\/s12028-021-01336-8.","journal-title":"Neurocrit Care"},{"key":"2257_CR25","doi-asserted-by":"publisher","first-page":"F1317","DOI":"10.1152\/ajprenal.00536.2012","volume":"304","author":"M Li","year":"2013","unstructured":"Li M, Wang X, Aa J, et al. GC\/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db\/db mice involved in diabetic nephropathy. Am J Physiol-Renal. 2013;304:F1317\u201324.","journal-title":"Am J Physiol-Renal"},{"key":"2257_CR26","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/s41467-022-30227-5","volume":"13","author":"I Thomas","year":"2022","unstructured":"Thomas I, Dickens AM, Posti JP, et al. Serum metabolome associated with severity of acute traumatic brain injury. Nat Commun. 2022;13:2545.","journal-title":"Nat Commun"},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13054-023-04573-9","volume":"27","author":"MM Banoei","year":"2023","unstructured":"Banoei MM, Lee CH, Hutchison J, et al. Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months. Crit Care. 2023;27:295.","journal-title":"Crit Care"},{"issue":"19","key":"2257_CR28","doi-asserted-by":"publisher","first-page":"10865","DOI":"10.3390\/ijms221910865","volume":"22","author":"M Palmieri","year":"2021","unstructured":"Palmieri M, Frati A, Santoro A, et al. Diffuse axonal injury: clinical prognostic factors, molecular experimental models and the impact of the trauma Related oxidative stress. An extensive review concerning milestones and advances. Int J Mol Sci. 2021;22(19):10865. https:\/\/doi.org\/10.3390\/ijms221910865.","journal-title":"Int J Mol Sci"},{"key":"2257_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/jmri.26258","volume":"49","author":"X Chen","year":"2019","unstructured":"Chen X, Chen Y, Xu Y, et al. Microstructural and neurochemical changes in the rat brain after diffuse axonal injury. J Magn Reson Imaging. 2019;49:1069\u201377.","journal-title":"J Magn Reson Imaging"},{"key":"2257_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/neu.2016.4496","volume":"34","author":"J Ljungqvist","year":"2017","unstructured":"Ljungqvist J, Zetterberg H, Mitsis M, Blennow K, Skoglund T. Serum neurofilament light protein as a marker for diffuse axonal injury: results from a case series study. J Neurotraum. 2017;34:1124\u20137.","journal-title":"J Neurotraum"},{"key":"2257_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/diagnostics10020117","volume":"10","author":"SH Jang","year":"2020","unstructured":"Jang SH. Diagnostic problems in diffuse axonal injury. Diagnostics. 2020;10:117.","journal-title":"Diagnostics"},{"key":"2257_CR32","doi-asserted-by":"publisher","first-page":"6564585","DOI":"10.1155\/2021\/6564585","volume":"2021","author":"A Alahmari","year":"2021","unstructured":"Alahmari A. Blood-brain barrier overview: structural and functional correlation. Neural Plast. 2021;2021:6564585.","journal-title":"Neural Plast"},{"issue":"22","key":"2257_CR33","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.3390\/nu14224725","volume":"14","author":"S Manninen","year":"2022","unstructured":"Manninen S, Silvennoinen S, Bendel P, et al. Carnitine intake and serum levels associate positively with postnatal growth and brain size at term in very preterm infants. Nutrients. 2022;14(22):4725. https:\/\/doi.org\/10.3390\/nu14224725.","journal-title":"Nutrients"},{"key":"2257_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.injury.2017.11.005","volume":"49","author":"BF Vardon","year":"2018","unstructured":"Vardon BF, Faure G, Rouget A, et al. Plasma free carnitine in severe trauma: Influence of the association with traumatic brain injury. Injury. 2018;49:538\u201342.","journal-title":"Injury"},{"key":"2257_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ebiom.2016.07.015","volume":"12","author":"M Oresic","year":"2016","unstructured":"Oresic M, Posti JP, Kamstrup-Nielsen MH, et al. Human serum metabolites associate with severity and patient outcomes in traumatic brain injury. EBioMedicine. 2016;12:118\u201326.","journal-title":"EBioMedicine"},{"key":"2257_CR36","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1089\/neu.2017.5272","volume":"35","author":"AM Dickens","year":"2018","unstructured":"Dickens AM, Posti JP, Takala R, et al. Serum metabolites associated with computed tomography findings after traumatic brain injury. J Neurotraum. 2018;35:2673\u201383.","journal-title":"J Neurotraum"},{"key":"2257_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fneur.2017.00398","volume":"8","author":"JP Posti","year":"2017","unstructured":"Posti JP, Dickens AM, Oresic M, Hyotylainen T, Tenovuo O. Metabolomics profiling as a diagnostic tool in severe traumatic brain injury. Front Neurol. 2017;8:398.","journal-title":"Front Neurol"},{"key":"2257_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166078","volume":"1867","author":"V Palafox-Sanchez","year":"2021","unstructured":"Palafox-Sanchez V, Ying Z, Royes L, Gomez-Pinilla F. The interaction between brain and liver regulates lipid metabolism in the TBI pathology. BBA-Mol Basis Dis. 2021;1867: 166078.","journal-title":"BBA-Mol Basis Dis"},{"key":"2257_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153608","volume":"11","author":"R Tzekov","year":"2016","unstructured":"Tzekov R, Dawson C, Orlando M, et al. Sub-chronic neuropathological and biochemical changes in mouse visual system after repetitive mild traumatic brain injury. PLoS ONE. 2016;11: e153608.","journal-title":"PLoS ONE"},{"key":"2257_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1099800409346056","volume":"11","author":"AE Pasvogel","year":"2010","unstructured":"Pasvogel AE, Miketova P, Moore IM. Differences in CSF phospholipid concentration by traumatic brain injury outcome. Biol Res Nurs. 2010;11:325\u201331.","journal-title":"Biol Res Nurs"},{"key":"2257_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12028-020-01043-w","volume":"34","author":"YH Zhong","year":"2021","unstructured":"Zhong YH, Zheng BE, He RH, et al. Serum levels of HDL cholesterol are associated with diffuse axonal injury in patients with traumatic brain injury. Neurocrit Care. 2021;34:465\u201372.","journal-title":"Neurocrit Care"},{"key":"2257_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00234-020-02383-2","volume":"62","author":"RVG Figueira","year":"2020","unstructured":"Figueira RVG, Guedes CJ. Early computed tomography for acute post-traumatic diffuse axonal injury: a systematic review. Neuroradiology. 2020;62:653\u201360.","journal-title":"Neuroradiology"},{"key":"2257_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214381","volume":"14","author":"K Tomita","year":"2019","unstructured":"Tomita K, Nakada TA, Oshima T, et al. Tau protein as a diagnostic marker for diffuse axonal injury. PLoS ONE. 2019;14: e214381.","journal-title":"PLoS ONE"},{"key":"2257_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/TA.0000000000001852","volume":"85","author":"SS Humble","year":"2018","unstructured":"Humble SS, Wilson LD, Wang L, et al. Prognosis of diffuse axonal injury with traumatic brain injury. J Trauma Acute Care. 2018;85:155\u20139.","journal-title":"J Trauma Acute Care"},{"key":"2257_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fncel.2014.00429","volume":"8","author":"DG Siedler","year":"2014","unstructured":"Siedler DG, Chuah MI, Kirkcaldie MT, Vickers JC, King AE. Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments. Front Cell Neurosci. 2014;8:429.","journal-title":"Front Cell Neurosci"},{"key":"2257_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103984","volume":"78","author":"M Morrens","year":"2022","unstructured":"Morrens M, Coppens V. LC-MS biomarker diagnostics for neuroinflammatory disorders. EBioMedicine. 2022;78: 103984.","journal-title":"EBioMedicine"},{"issue":"3","key":"2257_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/metabo13030370","volume":"13","author":"M Mentzelou","year":"2023","unstructured":"Mentzelou M, Papadopoulou SK, Papandreou D, et al. evaluating the relationship between circadian rhythms and sleep, metabolic and cardiovascular disorders: current clinical evidence in human studies. Metabolites. 2023;13(3):370.","journal-title":"Metabolites"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02257-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:04:49Z","timestamp":1757948689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02257-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02257-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4618162\/v1","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the local Institutional Review Board and registered at the Chinese Clinical Trial Registry (ChiCTR2100044352).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}